Blood miR-9/miR-124 concentration to assess the risk of neonatal bilirubin encephalopathy

Using blood miR-9/miR-124 concentration for early detection of the risk of neonatal bilirubin encephalopathy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047892

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Bilirubin Encephalopathy

Interventions

case series:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. To be included in the neonatal jaundiced encephalopathy patients admitted to Dujiangyan City People's Hospital from June 2021 to January 2022; 2. Neonatal, 48 hours.

Exclusion criteria

Exclusion criteria: Incomplete data collection.

Design outcomes

Primary

Measure	Time frame
blood miR-9/miR-124/miR-122;	—

Countries

China

Contacts

Public ContactXie Xiaoping

Dujiangyan People's Hospital

xiaoping_x65@sina.com+86 18081918125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026